Projects

IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities.

Keywords

Research group

Researcher

From date

To date

Allogeneic stem cell transplantation in HIV-1 infected individuals and 1st ITATI strategy

Project status

Ongoing

Start/End

2018

/

2020

Principal investigator

Javier Martínez-Picado

Participating entities

Foundation for AIDS Research amFAR (ARCHE program); ref 109858-64-RSRL
Treatment with immunological checkpoint inhibitors of HIV-infected subjects with cancer

Project status

Ongoing

Start/End

2018

/

2023

Principal investigator

Javier Martínez-Picado

Financing entity

Merck Sharp & Dohme de España, SA (MSD); ref IISP 57699
Characterisation of single molecule dynamics within HIV-1 reservoirs as a target for interference with virus persistence and immune evasion

Project status

Ongoing

Start/End

2019

/

2020

Principal investigator

Javier Martínez-Picado

Jakub Chojnacki

Financing entity

European Comission (H2020)
SIGTECH - New technologies mimicking virus-cell interaction to fight infectious diseases

Project status

Ongoing

Start/End

2018

/

2023

Principal investigator

Javier Martínez-Picado

Nuria Izquierdo Useros

Financing entity

Grifols
VIROCURE - Cutting edge strategies on HIV cure

Project status

Ongoing

Start/End

2018

/

2023

Principal investigator

Javier Martínez-Picado

Financing entity

Grifols
Exploratory, open-label, randomized clinical trial to assess the efficacy of first-line dual vs. triple antiretroviral therapy in HIV-1 reservoir and in peripheral compartments in HIV-infected patients

Project status

Ongoing

Start/End

2019

/

2021

Principal investigator

Javier Martínez-Picado

External researchers

José Moltó

Participating entities

AIDS Research Institute IrsiCaixa

Strategic lines

Global infectious diseases

Financing entity

ViiV Healthcare
Glycoengineering nanovehicles to purge viral reservoirs

Project status

Ongoing

Start/End

2018

/

2021

Principal investigator

Nuria Izquierdo Useros

Participating entities

ICN2 and Biofisika-CISC

Financing entity

Spanish Ministry of Economy and Competitiveness, ref. SAF2017-91767-EXP.
Halt the entry of enveloped viruses into immune cells: novel monoclonal antibodies and blockage of intracellular cascade

Project status

Ongoing

Start/End

2020

/

2023

Principal investigator

Javier Martínez-Picado

Participating entities

IrsiCaixa AIDS Research Institute

Strategic lines

Immunopathology

Financing entity

Spanish Ministry of Science and Innovation
3D human organoids for biomarker identification and treatment assessment in COVID-19 (3D4COVID)

Project status

Ongoing

Start/End

2020

/

2021

Principal investigator

Javier Martínez-Picado

Participating entities

IrsiCaixa AIDS Research Institute, Pompeu Fabra University (UPF)

Strategic lines

Cancer

Emerging infectious diseases

Financing entity

Merck SARS-CoV-2 competitive international call
Allogeneic Stem Cell Transplantation in HIV-1 Infected Individuals (IciStem)

Project status

Ongoing

Start/End

2015

/

2017

Principal investigator

Javier Martínez-Picado

External researchers

Annemarie Wensing (University Medical Center Utrecht)

Participating entities

IrsiCaixa AIDS Research Institute, University Medical Center Utrecht, Gregorio Marañón Hospital, Churchill Hospital at Oxford University, Institut Pasteur (Paris), University Medical Center Hamburg-Eppendorf, Cellex (Dresden)

Strategic lines

Immunopathology

Global infectious diseases

Therapies and vaccines

Web

IciStem

Financing entity

Foundation for AIDS research amfAR; (ARCHE program) 109293-59-RGRL